<![CDATA[Genetic Disorders]]> https://www.leadingmarketresearch.com/pharmaceuticals-biotechnology/pharmaceuticals/diseases-conditions/genetic-disorders Fri, 10 Apr 2026 06:00:08 +0000 Zend_Feed http://blogs.law.harvard.edu/tech/rss <![CDATA[Congenital Hyperinsulinism - Pipeline Insight, 2020]]> https://www.leadingmarketresearch.com/congenital-hyperinsulinism-pipeline-insight-2020 This “Congenital Hyperinsulinism - Pipeline Insight, 2020” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Congenital Hyperinsulinism pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Congenital Hyperinsulinism Understanding Congenital Hyperinsulinism: Overview Congenital hyperinsulinism is a condition that causes individuals to have abnormally high levels of insulin, which is a hormone that helps control blood sugar levels. People with this condition have frequent episodes of low blood sugar (hypoglycemia). In infants and young children, these episodes are characterized by a lack of energy (lethargy), irritability, or difficulty feeding. Repeated episodes of low blood sugar increase the risk for serious complications such as breathing difficulties, seizures, intellec...
$1,500.00
]]> Thu, 15 Oct 2020 12:43:30 +0000 <![CDATA[Argininosuccinic aciduria - Pipeline Insight, 2020]]> https://www.leadingmarketresearch.com/argininosuccinic-aciduria-pipeline-insight-2020 This “Argininosuccinic aciduria (ASA) - Pipeline Insight, 2020” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Argininosuccinic aciduria pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Argininosuccinic aciduria Understanding Argininosuccinic aciduria (ASA): Overview Argininosuccinic aciduria is an inherited disorder that causes ammonia to accumulate in the blood. Ammonia, which is formed when proteins are broken down in the body, is toxic if the levels become too high. The nervous system is especially sensitive to the effects of excess ammonia. Argininosuccinic aciduria usually becomes evident in the first few days of life. An infant with argininosuccinic aciduria may be lacking in energy (lethargic) or unwilling to eat, and have a poorly controlled breathing rate ...
$1,500.00
]]> Thu, 15 Oct 2020 12:43:30 +0000 <![CDATA[Global Genetic Diseases, Cancer, Forensic and Paternity Molecular Testing: US, Europe, Japan-Supplier Shares, Country Segment Forecasts, Emerging Technologies, Competitive Landscape ]]> https://www.leadingmarketresearch.com/global-genetic-diseases-cancer-forensic-and-paternity-molecular-testing The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget.

This new seven-country study from VPGMarketResearch contains 570 pages, 42 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years....

$5,400.00
]]> Wed, 06 Feb 2019 14:30:01 +0000 <![CDATA[Europe Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: France, Germany, Italy, Spain, UK--Supplier Shares, Country Segment Forecasts, Emerging Technologies, Competitive Landscape ]]> https://www.leadingmarketresearch.com/europe-genetic-diseases-cancer-forensic-and-paternity-molecular-diagnosti-214594 The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget.

This new five-country study from VPGMarketResearch contains 495 pages, 28 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years....

$2,850.00
]]> Wed, 06 Feb 2019 14:30:01 +0000 <![CDATA[France Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Supplier Shares, Country Segment Forecasts, Emerging Technologies, Competitive Landscape ]]> https://www.leadingmarketresearch.com/france-genetic-diseases-cancer-forensic-and-paternity-molecular-diagnosti-216992 The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.

This new study from VPGMarketResearch contains 407 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years....

$1,200.00
]]> Wed, 06 Feb 2019 14:30:01 +0000 <![CDATA[Germany Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Supplier Shares, Country Segment Forecasts, Emerging Technologies, Competitive Landscape ]]> https://www.leadingmarketresearch.com/germany-genetic-diseases-cancer-forensic-and-paternity-molecular-diagnost-216993 The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.

This new study from VPGMarketResearch contains 407 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years....

$1,200.00
]]> Wed, 06 Feb 2019 14:30:01 +0000 <![CDATA[U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Supplier Shares, Country Segment Forecasts, Emerging Technologies, Competitive Landscape ]]> https://www.leadingmarketresearch.com/u-s-genetic-diseases-cancer-forensic-and-paternity-molecular-diagnostic-216999 The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.

This new study from VPGMarketResearch contains 430 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years. ...

$1,750.00
]]> Wed, 06 Feb 2019 14:30:01 +0000 <![CDATA[Italy Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Supplier Shares, Country Forecasts, Emerging Technologies, Competitive Landscape ]]> https://www.leadingmarketresearch.com/italy-genetic-diseases-cancer-forensic-and-paternity-molecular-diagnostic-216994 The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.

This new study from VPGMarketResearch contains 402 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years....

$1,200.00
]]> Wed, 06 Feb 2019 14:30:01 +0000 <![CDATA[Japan Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Supplier Shares, Country Segment Forecasts, Emerging Technologies, Competitive Landscape ]]> https://www.leadingmarketresearch.com/japan-genetic-diseases-cancer-forensic-and-paternity-molecular-diagnostic-216995 The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.

This new study from VPGMarketResearch contains 410 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years....

$1,450.00
]]> Wed, 06 Feb 2019 14:30:01 +0000 <![CDATA[U.K. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Supplier Shares, Country Segment Forecasts, Emerging Technologies, Competitive Landscape ]]> https://www.leadingmarketresearch.com/u-k-genetic-diseases-cancer-forensic-and-paternity-molecular-diagnostic-212868 The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.

This new study from VPGMarketResearch contains 408 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years. ...

$1,200.00
]]> Wed, 06 Feb 2019 14:30:01 +0000 <![CDATA[Spain Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Supplier Shares, Country Segment Forecasts, Emerging Technologies, Competitive Landscape ]]> https://www.leadingmarketresearch.com/spain-genetic-diseases-cancer-forensic-and-paternity-molecular-diagnostic-216996 The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.

This new study from VPGMarketResearch contains 407 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years....

$1,200.00
]]> Wed, 06 Feb 2019 14:30:01 +0000 <![CDATA[Epiomic Epidemiology Series: Fragile X Syndrome Forecast in 11 Major Markets 2016-2026]]> https://www.leadingmarketresearch.com/epiomic-epidemiology-series-fragile-x-syndrome-forecast-in-11-major-market Fragile X syndrome (FXS) is an X-linked dominant genetic disorder. It is caused by a defect in the fragile-X mental retardation 1 gene (FRM1); this defect prevents the FRM1 gene from expressing FMRP. The FMRP protein, most commonly found in the brain, is essential for normal cognitive development and female reproductive function. FXS is the leading genetically inherited cause of intellectual and developmental disability. This report provides the current prevalent population for Fragile X Syndrome across 11 Major Markets (USA, France, Germany, Italy, Spain, UK, Australia, Japan, Brazil, India and China) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity. Providing a value-added level of insight from our analysis team, several of the main symptoms and co-morbidities of Fragile-X have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are...
$6,400.00
]]> Wed, 30 Nov 2016 13:10:00 +0000 <![CDATA[Cystic fibrosis- Market Insights, Epidemiology and Market Forecast-2023]]> https://www.leadingmarketresearch.com/cystic-fibrosis-market-insights-epidemiology-and-market-forecast-2023 Note*: This report requires 7-10 business days to complete. DelveInsight’s Cystic fibrosis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Cystic fibrosis forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Cystic fibrosis till 2023. Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the global Cystic fibrosis market. • Identifying patient populations in the global “Cystic fibrosismarket to improve product design, pricing, and launch plans. • Organize sales and marketing efforts by identifying the best opportunities for Cystic fibrosis therapeutics in each of the markets covered. • To und...
$4,950.00
]]> Wed, 24 Aug 2016 13:19:26 +0000 <![CDATA[Autism spectrum disorder (ASD)- Market Insights, Epidemiology and Market Forecast-2023]]> https://www.leadingmarketresearch.com/autism-spectrum-disorder-asd-market-insights-epidemiology-and-market-fo Note*: This report requires 7-10 business days to complete. DelveInsight’s Autism spectrum disorder (ASD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Autism spectrum disorder (ASD) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Autism spectrum disorder (ASD) till 2023. Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the global Autism spectrum disorder (ASD) market. • Identifying patient populations in the global “Autism spectrum disorder (ASD)market to improve product design, pricing, and launch plans. • Organize sales and marketing efforts by identifying the best opportunities for Autis...
$4,950.00
]]> Wed, 24 Aug 2016 13:19:26 +0000